In addition, a newly acquired CDKN2A deletion was detected at that time (Table 1), which is known to promote lung cancer progression, and the tumor cells showed a higher-grade morphology at this time compared to initial diagnosis (Fig. 2E–K vs. L–R) (Liu et al. 2020). This evidence concerns the gene CDKN2A and lung carcinoma.